Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy
Makaleler > Tam Makale · 2017
Yazarlar: Ira M. JACOBSON, Mary K. Washington, Maria BUTI, Alexander THOMPSON, Nezam Afdhal, Robert FLISIAK, Ulus Salih AKARCA, Konstantin G. TCHERNEV, John F. FLAHERTY, Raul Aguilar SCHALL, Robert P. MYERS, G. Mani SUBRAMANIAN, John G. MCHUTCHISON, Zobair YOUNOSSI, Patrick MARCELLIN, Keyur Patel
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2017, cilt 15, ss 1087-1094.e2
DOI: 10.1016/j.cgh.2017.01.032
Özet
BACKGROUND & AIMS: Despite complete suppression of viral DNA with antiviral agents, in some patients with chronic hepatitis B (CHB), serum levels of alanine aminotransferase (ALT) do not normalize. We investigated factors associated with persistent increases in ALT level in patients with CHB given long-term tenofovir disoproxil fumarate.